Related Experiment Video
Updated: May 1, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Role of AMP-activated protein kinase in cancer therapy
Gauhar Rehman1, Adeeb Shehzad, Abdul Latif Khan
1School of Life Science, College of Natural Science, Kyungpook National University, Daegu, South Korea; Department of Zoology, Abdul Wali Khan University, Mardan, K. P. K. Pakistan.
Abstract:
Recent advances in AMP-activated protein kinase (AMPK) as a target in cancer waxed and waned over the past decade of cancer research. AMPK is a cellular energy sensor, present in almost all eukaryotic cells. An elevated AMP/ATP ratio activates the AMPK, which in turn inhibits energy-consuming processes and induces catabolic events that generate ATP to restore the energy homeostasis inside the cell. Several reports have indicated that AMPK regulates several metabolic pathways and may be a potential therapeutic target for the treatment of cancer. Cancer cells have specific metabolic changes that differ from normal cells, and AMPK prevents the deregulated processes in cancer. AMPK may also act to inhibit tumor formation through modulation of cell growth, cell proliferation, autophagy, stress responses, and cell polarity. AMPK has been shown to inhibit mammalian target of rapamycin (mTOR) through tuberous sclerosis complex 2 (TSC2) phosphorylation and phosphatase and tensin homolog (PTEN), considered as central cell growth controller signals in diseases. In response to glucose deprivation, AMPK phosphorylates and activates p53, which induces cell cycle arrest in the G1/S phase of the cell cycle. AMPK has also been reported to block cyclin-dependent kinases through phosphorylation of p27(kip1) , promoting its stabilization and allowing cells to survive metabolic stress via induction of autophagy. Additionally, AMPK induces autophagy by phosphorylation and activation of eEF-2 kinase, and prevents the formation of new proteins. AMPK activators are also used for the treatment of type II diabetes and cancer. This review focuses on AMPK activation and its possible therapeutic role in the treatment of cancer.
Insights
AMP-activated protein kinase (AMPK) is a cellular energy sensor that plays a crucial role in cancer. This review explores AMPK activation and its therapeutic potential for cancer treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- AMP-activated protein kinase (AMPK) functions as a cellular energy sensor in eukaryotic cells.
- Elevated AMP/ATP ratios activate AMPK, inhibiting energy consumption and promoting ATP generation to maintain cellular energy homeostasis.
- AMPK regulates metabolic pathways and has emerged as a potential therapeutic target in cancer research due to cancer cells' altered metabolism.
Purpose of the Study:
- To review the activation mechanisms of AMPK.
- To explore the therapeutic role of AMPK in cancer treatment.
- To discuss AMPK's modulation of key cancer-related pathways.
Main Methods:
- Literature review of recent advances in AMPK research related to cancer.
- Analysis of AMPK's role in cellular metabolism and energy homeostasis.
- Examination of AMPK's interactions with key signaling pathways involved in cancer, such as mTOR, p53, and autophagy.
Main Results:
- AMPK activation inhibits energy-consuming processes and promotes ATP generation.
- AMPK plays a role in inhibiting tumor formation by modulating cell growth, proliferation, autophagy, stress responses, and cell polarity.
- AMPK inhibits mTOR signaling via TSC2 and PTEN phosphorylation.
- AMPK activates p53 in response to glucose deprivation, inducing cell cycle arrest.
- AMPK stabilizes p27(kip1), promoting survival via autophagy during metabolic stress.
- AMPK induces autophagy and inhibits protein synthesis through eEF-2 kinase activation.
Conclusions:
- AMPK is a critical regulator of cellular energy metabolism with significant implications for cancer.
- AMPK activation demonstrates potential as a therapeutic strategy for cancer treatment.
- Further research into AMPK activators could lead to novel cancer therapies, potentially also benefiting type II diabetes treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
MAPK Signaling Cascades

